Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Photo of Jeffrey Settleman
Individual Investor

Jeffrey Settleman

Overview

Edit Overview Section
CB Rank (Investor) 282,956
  • Gender Male
  • Also Known As Dr. Jeff Settleman
  • Investor Type 
    obfuscation
Dr. Jeff Settleman joined Pfizer in 2019 as the Chief Scientific Officer of the Oncology Research & Development Group.

Partner Investments

Edit Partner Investments Section
Number of Partner Investments 1
Announced Date  
Organization Name  
Investor Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
ORIC Pharmaceuticals Logo
ORIC Pharmaceuticals
Pfizer Logo
Pfizer
Yes
Post-IPO Equity - ORIC Pharmaceuticals Logo
Post-IPO Equity - ORIC Pharmaceuticals
obfuscation

Jobs

Edit Jobs Section
Number of Current Jobs 1
Jeffrey Settleman is the Chief Scientific Officer at Pfizer.

Recent News and Activity

Edit Recent News and Activity Section
There is no recent news or activity for this profile.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8fe006b 1)
|